Pharmacological properties of N-benzyl-salsolidine, a new isoquinoline derivative.
D000470:Alkaloids / Q000009:adverse effects / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D001593:Benzyl Compounds / Q000009:adverse effects / Q000494:pharmacology / Q000633:toxicity; D001794:Blood Pressure / Q000187:drug effects; D001919:Bradycardia / Q000139:chemically induced; D002490:Central Nervous System / Q000187:drug effects; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005260:Female; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D007546:Isoquinolines / Q000009:adverse effects / Q000494:pharmacology* / Q000633:toxicity; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D009130:Muscle, Smooth / Q000187:drug effects; D012640:Seizures / Q000139:chemically induced
D000470:Alkaloids; D001593:Benzyl Compounds; D007546:Isoquinolines